lobbying_activities: 3193127

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3193127	bc8c0297-1c46-497f-8c3f-95b68194987b	Q2	DESIMONE CONSULTING, LLC	400931695	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)	2024	second_quarter	PHA	Issues related to patient access and pricing. Issues related to policy changes to Medicare Part D. Issues related to PBM reform; H.R. 2880, Protecting Patients Against PBM Abuses Act and H.R.5376, Share the Savings with Seniors Act. Issues related to 340B reform; H.R.8574, To amend the Public Health Service Act to reform the 340B drug pricing program, and for other purposes. Issues related to the Ensuring Pathways to Innovative Cures (EPIC) Act, H.R.7174.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2024-07-16T07:52:10-04:00